Search

Your search keyword '"Johansen, Kari"' showing total 233 results

Search Constraints

Start Over You searched for: Author "Johansen, Kari" Remove constraint Author: "Johansen, Kari"
233 results on '"Johansen, Kari"'

Search Results

1. Contributors

3. Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016–17 and 2017–18)

4. Contributors

5. Contributors

8. The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns

11. Systematic review of the efficacy, effectiveness and safety of cell‐based seasonal influenza vaccines for the prevention of laboratory‐confirmed influenza in individuals ≥18 years of age.

12. Systematic review of the efficacy, effectiveness and safety of high‐dose seasonal influenza vaccines for the prevention of laboratory‐confirmed influenza in individuals ≥18 years of age.

13. Systematic review of the efficacy, effectiveness and safety of recombinant haemagglutinin seasonal influenza vaccines for the prevention of laboratory‐confirmed influenza in individuals ≥18 years of age.

14. Systematic review of the efficacy, effectiveness and safety of MF59® adjuvanted seasonal influenza vaccines for the prevention of laboratory‐confirmed influenza in individuals ≥18 years of age.

17. Systematic review of the efficacy, effectiveness and safety of MF59 adjuvanted seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age

19. Systematic review of the efficacy, effectiveness and safety of MF59 ® adjuvanted seasonal influenza vaccines for the prevention of laboratory‐confirmed influenza in individuals ≥18 years of age

20. Systematic review of the efficacy, effectiveness and safety of cell‐based seasonal influenza vaccines for the prevention of laboratory‐confirmed influenza in individuals ≥18 years of age

21. Systematic review of the efficacy, effectiveness and safety of high‐dose seasonal influenza vaccines for the prevention of laboratory‐confirmed influenza in individuals ≥18 years of age

22. Systematic review of the efficacy, effectiveness and safety of recombinant haemagglutinin seasonal influenza vaccines for the prevention of laboratory‐confirmed influenza in individuals ≥18 years of age

23. Operasjonssykepleieres holdninger til pasientsikkerhet og betydningen av simuleringsbasert trening

27. 2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children

29. Norovirus strains belonging to the GII.4 genotype dominate as a cause of nosocomial outbreaks of viral gastroenteritis in Sweden 1997–2005: Arrival of new variants is associated with large nation-wide epidemics

33. Allergic disease and atopic sensitization in children in relation to measles vaccination and measles infection

34. Towards elimination: measles susceptibility in Australia and 17 European countries/Sensibilitie a la rougeole en Australie et dans 17 pays europeens : vers une elimination de cette maladie/Hacia la eliminacion: vulnerabilidad al sarampion en Australia y en 17 paises europeos

35. Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets/Seroepidemiologie de la rubeole : comparaison entre 17 days des progres realises vers les objectifs internationaux de lutte contre cette maladie/Comparacion de la seroepidemiologia de la rubeola en 17 paises: progresos hacia las metas internacionales de control de la enfermedad

36. High genetic diversity of measles virus, World Health Organization European Region, 2005-2006

38. European seroepidemiology network 2: Standardisation of assays for seroepidemiology of varicella zoster virus

44. Detection of new SARS-CoV-2 variants related to mink

47. Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically-attended influenza: results of the European I-MOVE multicentre test-negative case-control study, 2011/12-2016/17

50. Data and product needs for influenza immunization programs in low- and middle-income countries: Rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccines

Catalog

Books, media, physical & digital resources